A Pfizer and Cytel veteran on why statisticians belong at trial design, and why fewer sponsors keep them in-house.
- How AI Is Used To Predict Trial Performance Before Enrollment
- Two Planning Mistakes That Quietly Sink Clinical Programs
- Token Costs Will Decide Clinical Supply AI
- A Framework For Diagnosing Clinical Research Technology Maturity
- Clinical Trial Sites Don't Need More Tech, They Need Fewer Silos
- A Biostatistician's Caution Around Digital Twins In Trials
- Who Owns Data Quality? The Authority Gap Slowing Trials
- Clinical Research Isn't Even A Recognized Job. That's A Problem.
ON-DEMAND WEBINARS
Research shows that the global DCT market will reach $14B by 2026. Research also suggests that up to 90% of clinical trials are at risk of failure. Faulty trial designs, patient retention, costs and flawed data collection are drivers for the failure rate in clinical trials. The risks of study failure are reduced by taking a patient- first enterprise platform approach.
See how AI handles real site documents in real time and walk away with a practical, honest look at what modern data capture could mean for your trial operations.
Join the Co-CEO of CRIO, as he explores research site challenges and how site-based technologies can reduce administrative burdens, enhance efficiency, and eliminate redundant one-time-use technologies.
Explore how clinical trial sponsors can benefit from the growing use of electronic source (eSource) technology at research sites.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages- 1180547354 trial data]( "Simplifying The Data Journey From EHR To EDC")
Simplifying The Data Journey From EHR To EDCExplore how open API architecture represents a significant advancement in the integration of EHR and EDC systems, enhancing the potential of EHR data for clinical research.
-
![GettyImages-1172429034 doctor ipad]( "Enhancing Oncology Trials With Clinical Platform Solutions")
Enhancing Oncology Trials With Clinical Platform SolutionsThis example involves a top 10 pharmaceutical company and explores how they were able to improve oncology trial efficiency, safety, patient experience, and more using a platform approach.
-
![GettyImages-944060504 coworkers computer]( "5 Benefits Of Using A Study Management Tool")
5 Benefits Of Using A Study Management ToolSee how study management tools simplify clinical trial management by centralizing all study information, enhancing efficiency and precision, and more.
-
![GettyImages-868669738 eCOA]( "eCOA Solution Design Recommendations: Applied Insights From Trial Sites, CRAs")
eCOA Solution Design Recommendations: Applied Insights From Trial Sites, CRAsEnhance hybrid trials with digitalization through remote data capture using smartphones, tablets, and computers, improving participant experience and data integrity.
-
![GettyImages-1371324023 site payments]( "How Can Sponsors Enable Research-Naïve Clinical Trial Sites")
How Can Sponsors Enable Research-Naïve Clinical Trial SitesClinical trial capacity in the U.S. is heavily concentrated, and technology is playing a critical role in enabling a shift to expanding site networks and alleviating the burden on sites and patients.
-
![More Shots On Goal Using A Developability Assessment Tool]( "The Language Of eCOAs")
The Language Of eCOAsIn this article, learn more about COAs, and their electronic counterparts, eCOAs.
-
![GettyImages-2032712502-scientists-tablet-training-labratory]( "Endpoint Adjudication Best Practices: What Top Teams Do Differently")
Endpoint Adjudication Best Practices: What Top Teams Do DifferentlyPoorly designed endpoint adjudication risks trial delays and data errors. Learn to optimize your process by aligning data capture, finalizing charters early, and using true arbitration.
-
![COVID 19 Coronavirus Mask Wearer]( "Our Unified Platform Serves As eSource For COVID Treatment Trial")
Our Unified Platform Serves As eSource For COVID Treatment TrialSignant Biotech optimized technology for an emerging biopharmaceutical's Phase 2 COVID treatment trial in critically ill patients, minimizing paper data risks and streamlining consent and data management across multiple sites and solutions.
-
![Navigate A Path]( "Taking eCOA Technology Deployment Off The Critical Path")
Taking eCOA Technology Deployment Off The Critical PathConsider this expedited review approach to facilitate the efficient evaluation of COAs and eCOAs, streamlining the pathway for successful trial execution.
-
![GettyImages-1180897630 consent]( "Kicking Off A Clinical Trial The Right Way - With Seamless Digital Consent")
Kicking Off A Clinical Trial The Right Way - With Seamless Digital ConsentRead this blog to learn more about how eConsent can enhance participant engagement and retention when used both onsite and remotely.
- Why The Biostatistician's Seat At The Table Keeps Vanishing
- From 73% Noncompliant To 2.4%: Building A Compliance Office
- How AI Is Used To Predict Trial Performance Before Enrollment
- Two Planning Mistakes That Quietly Sink Clinical Programs
- A Framework For Diagnosing Clinical Research Technology Maturity
RECENT NEWSLETTERS
- 09.24.26 -- AI, Wearables, And CRA Workflows Are Exposing Trial Gaps
- 09.17.26 -- AI, Wearables, And eTMF Are Exposing Trial Data Gaps
- 09.10.26 -- AI, Trial Costs, And RTSM Are Reshaping Clinical Operations
- 09.05.26 -- Best Of August: AI, FDA RWE, And Trial Data Risks
- 09.03.26 -- AI, APIs, and eConsent Are Exposing Trial Workflow Gaps
